Edition:
United States

Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

4.55DKK
9:23am EDT
Change (% chg)

kr.-0.08 (-1.73%)
Prev Close
kr.4.63
Open
kr.4.63
Day's High
kr.4.63
Day's Low
kr.4.41
Volume
434,458
Avg. Vol
157,449
52-wk High
kr.5.20
52-wk Low
kr.2.80

Chart for

About

Neurosearch A/S (NEUR) is Denmark-based biopharmaceutical company. It specializes in the research, development and sale of drug candidates. The Company’s portfolio comprises three products: Tesofensine, a drug used in obesity, which works as a monoamine reuptake inhibitor (MRI); Seridopidine, which is applied in central nervous... (more)
No analyst recommendations are available for .

Overall

Beta: 0.24
Market Cap(Mil.): kr.113.68
Shares Outstanding(Mil.): 24.55
Dividend: --
Yield (%): --

Financials

  NEUR.CO Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -0.46 -- --
ROI: -16.32 1.50 12.72
ROE: -16.32 0.19 14.85

BRIEF-RegNeurosearch And Teva Pharmaceutical International Enter Into Agreement On Outstanding Obligations

* REG-NEUROSEARCH AND TEVA PHARMACEUTICAL INTERNATIONAL ENTER INTO AGREEMENT ON OUTSTANDING OBLIGATIONS

May 16 2018

BRIEF-Neurosearch: Gefion To Launch A Takeover Offer On Neurosearch

* RECEIVED A NOTICE FROM GEFION GROUP INVESTMENTS A/S THAT GEFION DECIDED TO LAUNCH A CONDITIONAL, VOLUNTARY TAKEOVER OFFER

Apr 27 2018

BRIEF-Neurosearch Says Is Investigating Potential Sale Of Company

* SAYS IS IN DISCUSSIONS WITH REGARD TO POTENTIAL SALE OF ITS RIGHTS TO PRIDOPIDINE FOR A SMALL SEVEN FIGURE AMOUNT IN DKK

Apr 19 2018

Earnings vs. Estimates

No consensus analysis data available.